Lexology July 31, 2024
The PBM regulatory landscape is rapidly evolving at both federal and state levels, making it critical for our clients involved in the PBM space to stay apprised of developments in the industry as they happen. Our team actively monitors these developments to provide you with this PBM Policy and Legislative Update. This update builds on prior issues and highlights federal and state activity from January 2024 through June 2024.
FEDERAL LEGISLATIVE ACTIVITY AND OVERSIGHT
Federal Legislative Activity
Prescription Drug Supply Chain Pricing Transparency Act (H.R. 7535). On March 5, 2024, Representatives Yadira Caraveo (D-CO) and Tracey Mann (R-KO) introduced a bipartisan bill to require the United States Comptroller General to study and report on price-related compensation and payment structures in...
Today's Sponsors
Today's Sponsor